Clinical trials · Raleigh–Durham, NC
Myelodysplastic/Myeloproliferative Neoplasm clinical trials in Raleigh–Durham
We’re tracking 5 recruiting myelodysplastic/myeloproliferative neoplasm studies with a site in or near Raleigh–Durham — including Phase 1 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Raleigh–Durham
- NCT01137825Recruiting
Older patient cancer registry for a health check
This study is a registry that collects information from older adults who may be dealing with cancer. It includes a short health and function check to help doctors understand needs and guide care, even for people who turn out not to have cancer.
Raleigh, North CarolinaAges 65 years+ - NCT05554406RecruitingPhase 2
New drug therapy for high-risk AML
This trial is testing new drug combinations for people with newly diagnosed, high-risk AML who have not yet started treatment. It aims to find more effective therapies for this aggressive form of leukemia.
Durham, North CarolinaAges 18–59 - NCT05564390RecruitingPhase 2
MyeloMATCH screening to match you to AML or MDS treatment
This study screens people with newly suspected acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) to see which treatment approach fits best—either a specific study treatment or standard care. It may help by directing you to the right option and by sharing your blood/bone marrow samples for research.
Durham, North CarolinaAges 18 years+ - NCT01137643Recruiting
Sharing blood and tissue samples for blood cancer research
This trial collects tissue, blood, and other body fluid samples from people with blood-related cancers. The goal is to help researchers study these diseases by building a source of samples for future testing.
Chapel Hill, North CarolinaAges 18–120 - NCT04771572RecruitingPhase 1
Oral drug LP-118 for relapsed blood cancers
This Phase 1 study tests an oral (by mouth) drug called LP-118 in people whose blood cancers have returned or did not respond to prior treatment. The goal is to find a safe dose and see whether it can shrink or control the cancer.
Chapel Hill, North CarolinaAges 13 years+
Hear when a new Myelodysplastic/Myeloproliferative Neoplasm trial opens near Raleigh–Durham, NC
We’ll email you when one opens near Raleigh–Durham, NC — at most once a week, no account needed, unsubscribe anytime.
Myelodysplastic/Myeloproliferative Neoplasm trials in other cities
Where these studies are running near Raleigh–Durham
Institutions with a site for the recruiting myelodysplastic/myeloproliferative neoplasm studies listed above.
- UNC Lineberger Comprehensive Cancer Center · 3 studies
- Duke University Medical Center · 2 studies
- Rex Hematology Oncology Associates
- University of North Carolina at Chapel Hill
What taking part in a myelodysplastic/myeloproliferative neoplasm study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting myelodysplastic/myeloproliferative neoplasm studies in North Carolina.
Common questions
- Are there myelodysplastic/myeloproliferative neoplasm clinical trials near Raleigh–Durham?
- Yes. We're currently tracking 5 recruiting myelodysplastic/myeloproliferative neoplasm studies with a site near Raleigh–Durham, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a myelodysplastic/myeloproliferative neoplasm study near Raleigh–Durham?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Raleigh–Durham to take part?
- Not necessarily. These studies have a site near Raleigh–Durham, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a myelodysplastic/myeloproliferative neoplasm trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New myelodysplastic/myeloproliferative neoplasm studies open near Raleigh–Durham regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.